Click to Print This Page

 

CURRICULUM VITAE
PERSONAL DETAILS

Name
  Prof. Dr. Adeeba Binti Kamarulzaman
Designation
  Professor
Department
  Department of Medicine
Faculty
  Faculty of Medicine
Tel. No. (Office)
  03-79492129
E-mail Address
  adeeba@um.edu.my
ResearcherID Link
  http://www.researcherid.com/rid/B-5216-2010
Address(Office)
  Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, MALAYSIA

ACADEMIC QUALIFICATION
(Qualification), (Institution).
FRACP(1995) (AUS), ROYAL AUSTRALIASIAN COLLEGE OF PHYSICIANS
MBBS(1987) (AUS), MONASH UNIVERSITY, AUSTRALIA

PROFESSIONAL AFFILIATION/MEMBERSHIP
(Organisation), (Role), (Year), (Level).

Australasian Society for HIV Medicine, Member, (International)

Kementerian Kesihatan Malaysia, Member, 2013-2016, (National)

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Editorial Board Member, 2013-2016, (International)

Dewan Bahasa dan Pustaka, Expert Panel In medical and health sciences, 2013-2015, (National)

Kementerian Kesihatan Malaysia, Advisory Committee, 2013-2014, (National)

V11th HIV Treatment and Pathogenesis Conference, Kuala Lumpur,2013, Chairperson, 2013, (International)

University Malaya, Ahli Panel Kluster Penyelidikan Health & Translation Medicine, 2013-2014, (University)

Yale School of Medicine, Associate Adjunct Professor, 2012-2017, (International)

Programmatic Working Group. WHO Antoretroviral Guidelines Development Group, Co-Chair, Scientific & Research Sub-Commitee, 2012-2013, (International)

International AIDS Society, Governing Council Member, 2012-2016, (International)

Johnson & Johnson, Virology, Regional Advisory Board Member, 2012, (National)

Johnson& Johnson, Antimicrobials, Regional Advisory Board Member , 2012, (University)

WHO-Strategic and Technical Advisory Committee for HIV-AIDS (STAC-HIV), Co-Chair, Scientific & Research Sub-Commitee, 2011-2012, (International)

Academy of Science, Fellow, 2010, (National)

International Society of Infectious Diseases, Executive Committee Member, 2010-2016, (International)

PLoS ONE, Editorial Board Member, 2010, (International)

The Lancet Special Series : HIV and Injecting Drug Use , Guest Editor, 2009-2010, (International)

International AIDS Society, Co-Chair, Scientific & Research Sub-Commitee, 2008-2010, (International)

Australasian Society for Infectious Diseases, Member, 2008, (International)

Council Member International Society for Infectious Diseases - 2008, Council Member, 2008, (International)

International Association for Physicians in AIDS Care, Member, 2008, (International)

Malaysian Society for HIV Medicine , Member, 2008, (National)

Malaysian Society for Infectious Diseases and Chemotherapy , Member, 2008, (National)

Tulane University School of Public Health and Tropical Medicine, Adjacent Professor, 2008-2011, (International)

ARV4IDU, Editor, 2008, (International)

INTERNATIONAL JOURNAL OF DRUG POLICY, Editor, 2008, (International)

Oversight Committee for the Second Independant Evaluation of UNAIDS, Member, 2008, (International)

Scientific/Technical Advisory Group UNAIDS/UNICEF/ADB AIDS Data Hub(STAG), Member, 2008, (International)

Developing World Bioethics, Editor , 2007, (International)

United Nations Reference Group on HIV and Injecting Drug Use, Member, 2007, (International)

Academy of Medicine, Malaysia, Fellow, 2007, (National)

Global Initiatives Committee, Foundation for AIDS Reasearch (amfAR), New York, USA, Vice Chair, 2006-2010, (International)

Asia -Pacific Journal of Public Health, Editor, 2006, (International)

International Harm Reduction Association, Executive Committee Member, 2006, (International)

International Harm Reduction Development, Open Society Institute, New York, USA, Advisory Board Member, 2006, (International)

United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, Member, 2006, (International)

UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, Advisory Board Member, 2006, (University)

Asian Network on Surveillance of Resistant Pathogens (ANSORP), Steering Committee Member, 2005, (International)

Treat Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. Foundation for AIDS Research (amfAR), New York, USA, Steering Committee Member, 2005, (International)

Malaysian Harm Reduction Working Group, Panel, 2004, (National)

Asia-Pacific Council of AIDS Service Organisations, Board Member, 2002-2007, (International)

The Royal Australasian College of Physicians, Fellow, 1995, (International)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


Senate member, University Malaya, University Malaya, 01-Aug-10

Chair - Infection Control Committee , UMMC, University Malaya, 01-Jan-06 - 31-Dec-11

AREAS OF EXPERTISE
(Area).

Other Medical And Health Sciences Not Elsewhare Classified

Infectious/Communicable Diseases (Specialist In Infectious Diseases NSR)

RECENT SELECTED PUBLICATIONS
(Publication).
 
Book
 
2009

Is It HIV ? A handbook for healthcare providers. Australasian Soceity for HIV Medicine & Treat Sia . 2009, Editor 
 
2004

Rapid Situation Assessment of Malaysia 2004, G Reid, A Kamarulzaman, S Kaur . 1-41 

University Hospital Antibiotic Policy and Guidelines 2004 - 2006 . Editors A kamarulzaman , N Parasaktthi 
 
2000

Consensus Guidelines on the Management of Staphylococcus aureus infections . Editor A Kamarulzaman . April 2000 
 
1998

1st National Consensus Guidelines on Antiretroviral Therapy. October 1998 Editors C Lee, A Kamarulzaman, M Alias, N Othman 
 
Chapter In Book
 
2008

A Kamarulzaman, K Razali. The HIV epidemic in Malaysia. Public Health Aspects of HIV/AIDS in Developing Countries: Epidemiology, Prevention and Care. Editors C Beyrer, D Celentano Springer, New York 2008. 
 
2006

A Kamarulzaman. Sepsis. Management aspects of acute care. Eds: Chan YK, Ng KP. 2006:179-187 

P du Cros, A Kamarulzaman. HIV and Tuberculosis Coinfection. Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. Editor: M Curtis. International Harm Reduction Development Program. Open Society Institute. 2006 
 
2002

A Kamarulzaman. Common viral infections in Aisa . Principles and Practice of clinical Medicine in Asia. Treating the Asian Patient. Eds : JJY Sung, LKS Wong, PKT Li, J Sanderson, TCY Kwok. 2nd Edn : 2002 
 
1995

A Kamarulzaman, J Hoy. Cryptosporidia and microsporidia. In Fairfield Hospital HIV Handbook. Eds: F Bowden, A Mijch 1995; 43-44 
 
Article In Academic Journals
 
2014

Harry Jin, Valerie A. Earnshaw, Jeffrey A. Wickersham, Adeeba Kamarulzaman, Mayur M. Desai, Jacob John & Frederick L. Altice 2014. An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV,DOI: 10.1080/09540121.2014.894616 (ISI/SCOPUS Cited Publication)
 
2013

Reena Rajasuriara,Gabriela Khouryc,Adeeba Kamarulzaman, Martyn A. Frenche,Paul U.Cameronc,and Sharon R. Lewinc 
Persistent immune activation in chronic HIV.pdf

Mohd Zim MA, Sam IC, Omar SF, Cahn YF,Abu Bakar S,Kamarulzaman A. Chikungunya infection in Malaysia:Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol.2013 
Chikungunya infection in Malaysia.pdf

Wickersham JA,Zahari MM,Azar MM,Kamarulzaman A,Altice FL 
Methadone - 1-s2.0-S0376871613000173-main.pdf

Kamarulzaman A 
Fighting the HIV epidemic in the Islamic world.pdf

Ng KT, Lee YM, Al-Darraji HA, Xia X, Takebe Y, Chan KG, Lu L, Mahadeva S, Kamarulzaman A, Tee KK. 
Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia.pdf

Lee SS, Meintjes G, Kamarulzaman A, Leung CC 
Management of tuberculosis and latent tuberculosis infection in HIV-infected persons..pdf

Abed Al-Darraji HA, Abd Razak H, Ng KP, Altice FL, Kamarulzaman A 
The diagnostic Perfomance.pdf

Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia- Pacific HIV Observational Database (APHOD). 
Rates and Factors.pdf

Lim SH, Bazazi AR, Sim C, Choo M, Altice FL, Kamarulzaman A 
High Rates of unprocted anal.pdf

Ng KT, Ong LY, Lim SH, Takebe Y, Kamarulzaman A, Tee KK 
Evolutionary History of HIV-1 Subtype B and CRF01_AE Transmission Clusters among Men Who Have Sex with Men (MSM) in Kuala Lumpur, Malaysia.pdf

Chow WZ, Ong LY, Razak SH, Lee YM, Ng KT, Yong YK, Azmel A, Takebe Y, Al-Darraji HA, Kamarulzaman A, Tee KK 
Molecular diversity of HIV-1.pdf

Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A 
Absence of antiretroviraln therapy.pdf

Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; for the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies. 
Comparisons of Primary HIV-1.pdf

Larsson M, Shankar EM, Che KF, Saeidi A, Elleg R, Barathan M, Velu V, Kamarulzaman A. 
molecular signatures ofT-cell.pdf

Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N. 
viral hepatitis.pdf

Lubis R, Bulgiba A, Kamarulzaman A, Hairi NN, Dahlui M, Peramalah D 
Predictors of death in Malaysia.pdf
 
2012

Ford N, Kirby C, Singh K, Mills EJ, Cooke G, Kamarulzaman A,duCros P. 
WHO_Bulletin_2012_HCV_outcomes[1].pdf

Sam IC, Karunakaran R, Kamarulzaman A, Ponnampalavanar S, Syed Omar SF, Ng KP, Mohd Yusof MY, Hooi PS, Jafar FL, Abubakar S. A large exposure to Brucella melitensis in a diagnostic laboratory. J Hosp Infect 2012; 80(4):321-5. (ISI-Cited Publication)

Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database. J Int AIDS Soc. 2012 Jan 26;15(1):1. (ISI-Cited Publication)
Failure to prescribe pneumocystis.pdf

Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217. Epub 2012 Feb 22. (ISI-Cited Publication)
Loss to Followup in HIV-Infected Patients.pdf

Al-Darraji HA, Kamarulzaman A, Altice FL. Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. Epub 2012 Mar 7. (ISI-Cited Publication)
IPT_Correction_IJTLD - Final Version.pdf

Ford N, Singh K, Cooke GS, Mills EJ, von Schoen- Angerer T, Kamarulzaman A, du Cros P. Clin Infect Dis. 2012 May;54(10):1465-72. Epub 2012 Mar 19. (ISI-Cited Publication)
EXP ACCS TO TRTT FOR HEP C.pdf

Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, Kamarulzaman AB, Montaner J, Mounzer K, Saag M, Cahn P, Cesar C, Krolewiecki A, Sanne I, Montaner LJ. PLoS Med. 2012;9(4):e1001207. Epub 2012 Apr 17. (ISI-Cited Publication)
PRIORITIZING CD4 COUNT.pdf

Tee KK, Kamarulzaman A, Matano T, Takebe Y. Future Virol. (2012) 7(4), 405-414 (ISI-Cited Publication)
Tee at al 2012 Future Virol.pdf

Aghafar MZ, Witt C, Kamarulzaman A, Ismail R, Lederman MM, Rodriguez B, Senitzer D, Lee S, Price P. Tissue Antigens. 2012 May;79(5):367-71. doi: 10.1111/j.1399-0039.2012.01843.x. Epub 2012 Feb 2. (ISI-Cited Publication)
Genetic Variations.pdf

Chong YB, Tan LP, Robinson S, Lim SK, Ng KP, Keng TC, Kamarulzaman A. Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review. Tropical Biomedicine 29(2):270- 276 (2012) (ISI-Cited Publication)

Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; on behalf of the TREAT Asia Studies to Evaluate Resistance (TASER) and the TREAT Asia HIV Observational Database. Evaluating immunologic response and clinical deterioration in treatment-na patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2012 Nov 7 
Evaluating immunologic.pdf

Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18. 
Absence of Antiretroviral.pdf

Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; On behalf of the TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-na HIV-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012 Oct 24;5(1):582. 
Comparison of Predicted.pdf

Chow WZ, Al-Darraji H, Lee YM, Takebe Y, Kamarulzaman A, Tee KK. 
Genome Sequences CRF 53.pdf

Ng KT, OngLY, Takabe Y, Kamarulzaman A, Tee KK, 
Genome Sequenc 5401B.pdf

Jeffrey A Wickersham,Ruthanne Marcus,Adeeba Kamarulzaman, Muhammad Muhsin Zaharib & Frederick L Altice 
Implementing methadone maintenance treatment in prisons in Malaysia.pdf

Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance 
Cohort Profile.pdf

Smolak A, Gorroochurn P, Kamarulzaman A, Janjua N 
Asean Public Concern.pdf
 
2011

Tan LH, Fong MY, Mahmud R, Muslim A, Lau YL, Kamarulzaman A. (2011). Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitol Int 60: 111-113 (ISI-Cited Publication)

Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French M, Price P. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS. 2011 Jul 31;25(12):1455-60 

Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis. 2011 Apr 15;52(8):1053-7. 

Tan DB, Yong YK, Lim A, Tan HY, Kamarulzaman A, French M, Price P. Robust interferon- nd IL-12 responses by dendritic cells are related to efficient CD4(+) T-cell recovery in HIV patients on ART. Clin Immunol. 2011May;139(2):115-21. Epub 2011 Feb 23 

Kanter J, Koh C, Razali K, Tai R, Izenberg J, Rajan L, Van Griensven F, Kamarulzaman A. Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS. 2011 Jan;22(1):30-7. 

Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug Alcohol Depend. 2011 Jan 11. 
 
2010

Bux SI, Mohd. Ramli N, Ahmad Sarji S, Kamarulzaman A CHEST IMAGING FEATURES OF PATIENTS AFFLICTED WITH INFLUENZA A (H1N1) IN A MALAYSIAN TERTIARY REFERRAL CENTRE Biomed Imaging Interv J 2010; 6(4):e35 (SCOPUS-Cited Publication)

Adeeba Kamaruzzaman & Shaikh Mohd Saifuddeen. 2010. Islam and harm reduction. International Journal of Drug Policy 21(2): 115-118. (ISI-Cited Publication)

CE Lee, K Adeeba, G Freigang Human Plasmodium Knolesi Infections in Klang Valley, Peninsula Malaysia : A Case Series Med J Mal Vol 65 No 1 , March 2010 

Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010 Jun;21 (6):416-23 

Zahari MM, Bae WH, Zainal NZ, Habil H, Kamarulzaman A, Altice FL.Psychiatric and Substance Abuse Co-Morbidity Among HIV Seropositive and HIV Seronegative Prisoners in Malaysi. Am J Drug Alcohol Abuse.Jan;36(1);31-8 

Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. Int J Drug Policy. 2010 Mar;21(2):115-8. Epub 2009 Dec 16. 

Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010 Apr;84(7):3339-50. Epub 2010 Jan 20. 

Li Y, Tee KK, Liao H, Hase S, Uenishi R, Li XJ, Tsuchiura T, Yang R, Govindasamy S, Yong YK, Tan HY, Pybus OG, Kamarulzaman A, Takebe Y. Identification of a Novel Second- Generation Circulating Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. J Acquir Immune Defic Syndr. 2010 Apr 7. 

Takebe Y, Liao H, Hase S, Uenishi R, Li Y, Li XJ, Han X, Shang H, Kamarulzaman A, Yamamoto N, Pybus OG, Tee KK. Reconstructing the chronology of the expansion of HIV-1 in East Asia: the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC. Vaccine. 2010 May 26;28 Suppl 2:B39-44. 

Yue Li, BSc,Kok Keng Tee, PhD,Huanan Liao,PhD,Saiki Hase, PhD,Rie Uenishi,PhD,Xiao-Jie Li, MD, PhD,Takayo Tsuchiura, BSc,Rongge Yang, MD, PhD,Sumathi Govindasamy, BA,Yean Kong Yong, MMedSc, Hong Yien Tan, MMedSc,Oliver G. Pybus, PhD,k Adeeba Kamarulzaman,MBBS, FRACP,and Yutaka Takebe, MD, PhD.Identification of a Novel Second-Generation Circulating .Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. Feb 2010 

Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to Act : a call for comprehensive responses to HIV in people who use drugs.Lancet.2010Jul 20 

Altice FL,Kamarulzaman A, Soriano W,Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010 Jul 31;376(9738):367-87 

Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet . 2010 Jul 24;376(9737):208-11 

Tan DBA, Yong YK, Tan HY, French M, Kamarulzaman A, et al. (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS Clinic Res 1:102 doi:10.4172/2155-6113.1000102 

Sam, I-C., Kamarulzaman, A., Ong, G.S.Y., Veriah, R.S., Ponnampalavanar, S., Chan, Y.F. and AbuBakar, S. 2010. Chikungunya virus-associated death in Malaysia. Tropical Biomedicine 27(2): 343 347 (2010) (ISI-Cited Publication)

Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S,Ismail R, Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and caucasian human immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.doi: 10.1111/j.1399- 0039.2010.01570.x. [Epub ahead of print] PubMed PMID: 20887379 

Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, Wong MH, Syed Omar SF, Hussain SH. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect. 2010 Aug 11. (ISI-Cited Publication)

Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J,Sirisanthana T, Chen YM, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; on behalf of The TREAT Asia HIV Observational Databse. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010 Mar 21 

Lau KA, Wang B, Miranda-Saksena M, Boadle R, Kamarulzaman A, Ng KP, Saksena NK. Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B. Curr HIV Res. 2010 Apr 1;8(3):259-71. 

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010 Mar 20;375(9719):1014-28. 
 
2009

Benito N, Mir JM, de Lazzari E, Cabell CH, del R A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009 May 5;150(9):586-94 (ISI-Cited Publication)

Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV- infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009 Apr 1;48(7):940-50 (ISI-Cited Publication)

Tee KK, Takebe Y, Kamarulzaman A. Emerging and re- emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2009 May;13(3):307-18. 

Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kone P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Mir JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008 Oct 27;168(19):2095-103 (ISI-Cited Publication)

Tee KK, Pybus OG, Parker J, Ng KP, Kamarulzaman A, Takebe Y.Estimating the date of origin of an HIV-1 circulating recombinant form.Virology. 2009 Mar 7. 

Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009 Jul 28;73(4):315-20. 

Tee KK, Kusagawa S, Li XJ, Onogi N, Isogai M, Hase S, Uenishi R, Liao H, Kamarulzaman A, Takebe Y. Isolation and characterization of a replication- competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B)PLoS One. Aug 18;4 (8). 

Kamarulzaman A, Antiretroviral therapy in Malaysia; identifying barriers to universal access HIV Therapy. Nov , Vol. 3, No. 6, Pages 573-582 

Kamarulzaman A, Impact of HIV Prevention Programs on Drug Users in Malaysia . J Acquir Immune Defic Syndr .Nov;52 Suppl 1;S17-9 
 
2008

Sherman SG, Kamarulzaman A, Spittal P.Women and drugs across the globe: a call to action. Int J Drug Policy. 2008 Apr;19(2):97-8. 

Baddley JW, Benjamin DK Jr, Patel M, Mir J, Athan E, Barsic B, Bouza E,Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D,Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C; International Collaboration on Endocarditis- Prospective Cohort Study Group (ICE - PCS).Eur J Clin Microbiol Infect . Candida infective endocarditis. Dis. 2008 Jul;27(7):519-29. 

Tee KK, Pybus OG, Liao H, Uenishi R, Hase S, Kamarulzaman A, Li XJ, Takebe Y.Chronology of the HIV- 1 CRF07_BC expansion in East Asia. AIDS. 2008 Jan 2;22(1):156-8. 

33.Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 

Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1139-45. 

Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kamarulzaman A, Konecny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med. 2008 Oct 27; 168(19):2095-103 

Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2008 Nov 13 

Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Nov 15;372(9651):1733-45 

Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol. 2008 Sep;82(18):9206-15. 

Wright E, Brew B, Arayawichanont A, Robertson k, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffman S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, dwyer R, McCormack G, Hellard M, Cherry C, Mc Arthur J, Wesselingh S. Neurologic Disorders are Prevalent in HIV-posotive Outpatients in the Asia-Pacific Region. Neurology. 2008 Jul 1;71(1):50-6. 

Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altics FL. Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. AM J Drug Alcohol Abuse. 2008;24(4):511-7 

Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P. Immunological Profiles of Immune Restoration Disease Presenting as Mycobacterial Lymphadenitis and Cryptococcal Meningitis. HIV Med. 2008 May;9(5):307-16 

Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 
 
2007

Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007 Aug;18(4):306-12 

Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy. 2007 Mar;18(2):136-40 

Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007 Jul 31;21(12):1525-34. 

Wang B, Lau KA, Ong LY, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology. 2007 Oct 25;367(2):288-97. 

Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med. 2007 Jan;8(1):8-16. 

Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A. Emerging HIV Epidemics in Muslim Countries: Assessment of Different Cultural Responses to Harm Reduction and Implications for HIV Control. Cur HIV/AIDS Rep. 2007 Dec;4(4):151-7 
 
2006

Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 

Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):523-9. 

Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses. 2006 Feb;22(2):121-4. 

Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol. 2006 Jun;195(2):107-12. 

Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. J Postgrad Med. 2006 Jan-Mar;52(1):23-9; 
 
2005

Vinothini. A, Khoo, E.M. & Adeeba, K. 2005. Knowledge of HIV/AIDs in among pregnant women in an urban health clinic - a preliminary study. The Family Physician 13(1&2): 10-15 (Non-ISI/Non-SCOPUS Cited Publication)

Nurul Atifah MA, Loo HK, Subramaniam G, Wong EH, Selvi P, Ho SE, Kamarulzaman A, Parasakthi N. Faecal prevalence of extended-spectrum Beta-lactamase (ESBL)-producing coliforms in a geriatric population and among haematology patients. Malays J Pathol. 2005 Dec;27(2):75-81. 

Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50. 

Joazlina ZY, Wastie ML, Kamarulzaman A. Kostmann's syndrome. Clin Imaging. 2005 Sep-Oct;29(5):364-6. 

Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005 Jan;26(1):100-4. 

Adeeba Kamarulzaman .Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. 2005, Med. J. Malaysia, Vol. 60, no. 1, pg. 1-4 

Ranganathan S, Moosa F, Kamarulzaman A, Looi LM. MRI and CT findings of cryptococcal vaginitis. 2005, Br. J. Radiol., Vol. 78, no. 928, pg. 353-354 

Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50. 

Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG, The TREAT Asia HIV Observational Database: Baseline and Retrospective Data, 2005, J. Acquir. Immune Defic. Syndr., Vol. 138, no. 2, pg. 174-179 

Tee KK, Pon CK, Kamarulzaman A, Ng KP. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS. 2005 Jan 28;19(2):119-26. 
 
2004

Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis. 2004 Jun 1;38(11):1570-8 

Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, Ng TK, Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7. 

Oh WS, Suh JY, Song JH, Ko KS, Jung SI, Peck KR, Lee NY, Yang Y, Chongthaleong A, Chiu CH, Kamarulzaman A, Parasakthi N, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Carlos CC; ANSORP Study Group. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb Drug Resist. 2004 Spring;10(1):37-42 

Kamarulzaman A. Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Healt. 2004;16(1):1-2 
 
2002

Gan GG, Kamarulzaman A, Goh KY, Ng KP, Na SL, Soo-Hoo TS. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med J Malaysia. 2002 Mar;57(1):118-22. 

Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia. 2002 Sep;57(3):304-10. 

Tan LH, Kamarulzaman A, Liam CK, Lee TC. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. Infect Control Hosp Epidemiol. 2002 Oct;23(10):584-90. 

Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, Salem O, Vasudevan AE, Rosaida MS, Rosmawati M, Tan LH. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002 Feb;55(2):276-8. 
 
2001

Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, Chew NK, Chua KB, Lam SK. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001 Jun;49(6):810-3. 

Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 2001 Jan;42(1):40-3. 
 
2000

Tan SY, Tan LH, Teo SM, Thiruventhiran T, Kamarulzaman A, Hoh HB. Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient. Transplant Proc. 2000 Nov;32(7):1965-6. 

Chua KB, Lam SK, Tan CT, Hooi PS, Goh KJ, Chew NK, Tan KS, Kamarulzaman A, Wong KT. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann Neurol. 2000 Nov;48(5):802-5. 

Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229-35. 
 
1999

Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999 Oct 9;354(9186):1257-9 

Pakianathan MR, Kamarulzaman A, Ismail R, McMillan A, Scott GR. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients. AIDS. 1999 Sep 10;13(13):1787-8. No abstract available 
 
1996

Kamarulzaman A, Briggs RJ, Fabinyi G, Richards MJ. Skull osteomyelitis due to Salmonella species: two case reports and review. Clin Infect Dis. 1996 Apr;22(4):638-41. 
 
Mass Media(Newspaper,radio,tv,popular Magazine)
 
2013

The female face of HIV/AIDS 
The female face of HIVAIDS Star 8 March 13.pdf

FRONTLINER FOR HIV AIDS PROFESSOR DR ADEEBA KAMARULZAMAN ON THE CAUSE CLOSE TO HER HEART 
0616_HELLO_pg63_FRONTLINER FOR HIV AIDS PROFESSOR DR ADEEBA KAMARULZAMAN ON THE CAUSE.pdf

THE THIN RED LINE 
0612_MCL_PG178,179_THE THIN RED LINE.pdf

AN EVENING OF GLAMOUR AND GOODWILL THE MALAYSIAN AIDS COUNCIL ANNUAL 
0616_HELLO_pg60TO62_AN EVENING OF GLAMOUR AND GOODWILL THE MALAYSIAN AIDS COUNCIL ANNUAL.pdf

Adeeba Kamarulzaman and Bertrand Union . Winds of change on drug policy 
0626_Star_PG24_Winds of change on drug policy.pdf

Adeeba Kamarulzaman,Reena Rajasuriar 
NST May7 End of a Scourge.pdf

Adeeba Kamarulzaman. Penghidap HIV turun 
0626_BH_pg18_HIV turun Penghidap.pdf

Foundation receives RM25,000 - NST 
0613_NST_PG4_Foundation receives RM25,000.pdf
 
Others
 
1999

A Kamarulzaman, KJ Goh. Causes of viral encephalitis outbreaks in Malaysia and Australia. In UptoDate. Eds JG Bartlett, SB Calderwood, MS Hirsch, et al. 1999 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Source), (Level).

A Multicentre Study To Validate The Predictive Value Of Warning Signs In Dengue, Co-Investigator, 2011-2011, WHO, International

Diseases among poverty (A community based participatory action research project), Co-Investigator, 2011-2012, HTMC, Flag ship, National

Strengthening Epidemic Intelligence in Malaysia, Principal Investigator(PI), 2011-2011, HTMC, Flag ship

A phase 2B multicenter, randomized, comparative trial of UK-453.061 versus etravirine in combination with Darunavir/Ritonavir and a Nucleotide/Nucleoside reverse transcriptase inhibitor for the treatment of antiretroviral experienced HIV-1 infected subjects with evidence of NNRTI 0resistant HIV-1. A phase 2B/3 open-label rollover study for subjects discontinuing from the UK-453,061 protocols for the treatment of HIV-1 infected subjects. Sponsor : Pfizer, Principal Investigator(PI), 2010-2012, Pfizer, National

Social Determinants Epidemiological Routes of HIV/STI transmission Among Fishermen, Principal Investigator(PI), 2009-2011, Geran Penyelidikan Universiti Malaya (UMRG), National

A prospective observational cohort study of immune reconstitution and its consequences in immunodeficient HIV-infected patients treated with highly active anti-retroviral therapy., Co-Investigator, 2009-2011, Geran Penyelidikan Universiti Malaya (UMRG), National

An open non-comparative, multicentre study to assess the efficacy and safety of oral SB 265805 320 mg once daily for 7 days for the treatment of lower respiratory tract infections in adults. Sponsor: Smith-Kline Beecham International, Co-Investigator, 2008-2008, Smith-Kline Beecham International

Pilot Project: Introducing Methadone and HAART for Soon To Be Released HIV-Positive Prisoners in Pengkalan Chepa Kelantan, Co-Investigator, 2008-2008, Geran Penyelidikan Universiti Malaya (UMRG), National

Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Sponsor: National Institutes on Drug Abuse, USA, Principal Investigator(PI), 2008-2008, National Institutes on Drug Abuse, USA

A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study, Co-Investigator, 2008-2008, NCHECR, University of New South Wales

International Collaboration on Endocarditis (ICE) Prospective Cohort Study of Infective Endocarditis, Co-Investigator, 2008-2008, ICE

A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B followed by fluconazole in the treatment of candidaemia in non neutropaenic subjects, Co-Investigator, 2008-2008, PFIZER Inc

Genotypic and Phenotypic Characterization of Novel Human Immunodeficiency Virus Type 1 (HIV-1) Circulating Recombinant Form (CRF33_01B) in Malaysia, Principal Investigator(PI), 2007-2008, ScienceFund

Evaluation of Transmitted HIV Drug Resistance in Treatment Na ve, Recently Infected HIV Individuals. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER S, Co-Investigator, 2006-2008, TREAT Asia

A randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Conmbinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study, Principal Investigator(PI), 2006-2012, NCHECR, University of New South Wales, International

Monitoring and Evaluation of HIV Drug Resistance in Patients on Antiretroviral Therapy. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER M., Co-Investigator, 2006-2008, TREAT Asia, International

A randomized, controlled, open label-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment- experienced HIV-infected subjects Protocol: TMC114-214, Co-Investigator, 2005-2008, Tibotec

International collaborative study on epidemiological survey of HIV infections, isolation and characterisation of unique HIV-1 recombinants emerging in Malaysia., Principal Investigator(PI), 2005-2008, Japan Foundation for AIDS Prevention

Linezolid In The Treatment of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus Protocol: A5951001, Co-Researcher, 2004-2008, Pfizer

A prospective randomized, double-blind, placebo- controlled, dose ranging, multi-center study of the safety and efficacy of three days continuous intravenous infusion of GR270773 in the treatment of suspected or confirmed gram negative severe sepsis in adults, Co-Investigator, 2004-2008, GSK

Immune Reconstitution Disease in Severely Immuno- deficient AIDS patients commencing HAART Collaborator: University of Western Australia, Principal Investigator(PI), 2004-2008, University of Western Australia

TREAT Asia Observational Database, Co-Investigator, 2003-2008, amfAR

A Multi-faceted Study of HIV in Malaysia CIPRA R03 AI 56379-01, Principal Investigator(PI), 2003-2008, National Institute of Health, USA

LY333328 versus vancomycin in complicated skin/skin-structure infections. Protocol H4Q-MC-ARRI, Co-Investigator, 2001-2008, Eli - Lily

A cross sectional survey and prospective study on tuberculin skin reaction among healthcare workers at University Malaya Medical Centre, Co-Investigator, 2001-2008, Geran Penyelidikan Universiti Malaya (UMRG)

A Phase 111 study comparing the antiviral efficacy and safety of BMS-232632 with efavirenz, each in combination with fixed dose zidovudine-lamivudine, Co-Investigator, 2000-2008, Bristol-Myers Squibb

Clinical impact of antimicrobial resistance among invasive pneumococcal pathogens in Asian countries, Co-Investigator, 2000-2008, ANSORP

Prophylactic versus pre-emptive therapy of cytomegalovirus infection in bone marrow and solid organ transplant patients, Principal Investigator(PI), 1999-2008, IRPA

Efficacy and Safety of Oral Gatifloxacin versus oral amoxacillin with a treatment duration of 7 to 10 days in patients with bacterial community acquired pneumonia, Co-Investigator, 1999-2008, Grunenthal Gmbh

A Phase 1B Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV Positive Patients with No Previous Antiretroviral Therapy, Co-Investigator, 1999-2008, Sarawak Medichem Pharmaceuticals, National

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).

ASEAN Forum on HIV/AIDS. Port Dickson., Consultant, 2001-2001, Ministry of Health Malaysia

ASEAN Workshop for the Exchange of Experience on Increasing Access to Treatment and Care for PLWHA, Representative, 2002-2002, APCASO

ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, Representative, 2002-2002, APCASO

ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, Representative, 2002-2002, ASEAN

Confronting HIV among people who Inject Drugs - Kuala Lumpur Dec 09, Consultant, 2009-2009, Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015

Consultation on Ethics in Conducting Research in People Who Use Drugs 2 - UNAIDS, WHO. Kuala Lumpur , December 2010, 2010-2010, WHO

Consultation on Ethics in Conducting Research in People Who Use Drugs- UNAIDS. Istanbul, Consultant, 2010-2010, UNAIDS

Global Advocacy for Injecting Drug Use Bill and Melinda Gates Foundation, London, Consultant, 2008-2008, Bill and Melinda Gates Foundation

Institute of Medicine, National Academies of Sciences, USA. Prevention of HIV Infection among Injecting Drug Users in High Risk Countries An Assessment of the Evidence., Consultant, 2005-2005, Institute of Medicine, National Academies of Sciences, USA

Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015 Confronting HIV Among People Who Inject Drugs Kuala Lumpur, Consultant, 2009-2009, -

Special Session on HIV/AIDS. New York., Country Delegate, 2001-2001, United Nations General Assembly

UK Department for International Development HIV-AIDS Project. Towards a Strategy for Commonwealth Universities Geneva., Consultant, 2001-2001, Association of Commonwealth Universities

United Nations General Assembly Special Session on HIV/AIDS, Country Delegate, 2001-2001, United Nations

Visiting Consultant Physician, Clinical Consultant, 2000-2002, Institut Jantung Negara

WHO 2013 Consolidated guidelines on the use of antiretroviral for the treatment and prevention of HIV, Temporary Advisor, 2013-2013, WHO

WHO Global Strategy for Containment of Antimicrobial Resistance Geneva., Consultant, 2000-2000, World Health Organisation

Workshop on Notifiable Diseases., Consultant, 2000-2000, Ministry of Health Malaysia

World Health Organisation. HIV Testing and Counselling in IDU. Manila, Consultant, 2007-2007, World Health Organisation

World Health Organisation. HIV Testing and Counselling. Phnom Penh, Consultant, 2007-2007, World Health Organisation

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).

50 Emerging Women Leader in Asia Pacific 2011 Advance Australia, Australian Government, 2011, (INTERNATIONAL)

Anugerah Cermerlang Universiti Malaya 2012, University Malaya, 2012, (UNIVERSITY)

Australian Education Achievement Award 2012 ( Winner - Alumni Category ), Australian High Commissioner, Kuala Lumpur, 2012, (INTERNATIONAL)

Australian-Asian Fellowship Award, Australian Government, 2002, (INTERNATIONAL)

Certificate of Credentialing & Privileging, University Malaya, 2013, (UNIVERSITY)

Fellow in Infectious Diseases, Senior Medical Staff, Fairfield Hospital, 1995, (INTERNATIONAL)

Finalis Anugerah Perdana Menteri Penggiat Sosial Wanita 2011, Menteri Pembangunan Wanita, Keluarga dan Masyarakat, 2011, (NATIONAL)

International AIDS Fellowship Programme, International Society of Infectious Diseases, 1999, (INTERNATIONAL)

Merdeka Award, Exxon Mobil, Petronas and Shell, 2008, (NATIONAL)

Pingat Bakti Setia Jabatan Penjara Malaysia , Jabatan Penjara Malaysia, 2009, (NATIONAL)

Sijil Penghargaan - Jawatankuasa Majlis Penilaian Teknologi Kesihatan Dan Panduan Amalan Klinikal, Kementerian Kesihatan Malaysia, 2012, (NATIONAL)

Swarovski Life Ball Crystal of Hope Award, Austrian Life Ball, 2005, (INTERNATIONAL)

Tun Mahathir Science Award, Malaysian Academy of Science, 2008, (NATIONAL)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).
 
Pleanary/Keynote Speaker

Substance Abuse and Harm Reduction, XVII International AIDS Conference August 2008. Mexico City., 01 Aug 2008, (International)
 
Invited Seminar

, Seminar on Rights and Responsibilities of Government Doctors, 03 Nov 2012 to 03 Nov 2012, SCHOMOS / MOH, (National)

, The First ASEANS Deans' Summit : Connecting ASEAN Medical Schools towards One Community" - International Conference in Medicine and Public Health (ICMPH) 2012, 17 Sep 2012 to 17 Sep 2012, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, (International)
 
Invited Speaker

HIV care under universal coverage:challenges and choices, Global Public Health International Symposium on "Universal Coverage", 03 Oct 2011 to 01 Oct 2011, Monash University, (International)

HIV and Mobility, Asia Pacific Conference in Medical Virology 2012, 06 Jun 2012 to 08 Jun 2012, APCMV 2012 Congress, (International)

, 7th National Infectious Diseases Seminar and Workshop (NIDSAW)2012, 06 Nov 2013 to 06 Nov 2013, Universiti Putra Malaysia, (National)

Monash University Malaysia Graduation Address, Monash University Malaysia Graduation Address, 10 Apr 2010 to 10 Apr 2010, Monash University, (International)

Viral Hepatitis and HIV Coinfection, Singapore AIDS COnference, 17 Nov 2012 to 17 Nov 2012, Singapore AIDS Conference, (International)

HIV and AIDS in Muslim Countries, Women In Science and Technology in Muslim Countries, 21 Sep 2011, MOSTI, (National)

, 5th National Conference for Clinical Research 2011, 22 Jun 2011 to 24 Jun 2011, Ministry of Health Malaysia, (National)

Accreditation on Medical School, Summit on Medical Education 2013, 23 Aug 2013 to 23 Aug 2013, University Teknologi MARA, (National)

Carbapenem-resistant Pseudomonas and Acinetobacter, 13th International Congress in Infectious Diseases (ICID). Kuala Lumpur, 23 Jun 2008, International Society of Infectious Diseases, (International)

International Collaboration & Getting to Zero, 26th Annual Japan HIV Conference, 24 Nov 2012 to 26 Nov 2012, Japanese Society for AIDS Research, (International)

AIDS in Asia at the symposia on HIV, 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID), 25 Oct 2012 to 28 Oct 2012, 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID), (International)

HIV Prevention in Malaysia, Global Health Centre, Columbia University, Almaty, Kazakshtan. May 2010. HIV Prevention in Malaysia, 31 May 2010 to 31 May 2010, Columbia University, (International)
 
Presenter

, Islam and HIV/AIDS International Conference 2012, 19 Nov 2013 to 21 Nov 2013, Department of Islamic Development Malaysia, (National)
 
Others

Scalling up Harm Reduction in Malaysia, XIII th International Congress of AIDS in Asia and the Pacific (ICAAP)Aug 2009, 01 Aug 2009, AIDS Soceity Asia Pacific, (International)

International Experience of Harm Reduction, Xth International Conference of Drug Dependence. Xian, China. October 2008, 01 Oct 2008, The Chinese Society of Addiction Medicine, (International)

Substance Abuse and Harm Reduction in Malaysia, XV111 International AIDS Conference July 2010. Vienna. Substance Abuse and Harm Reduction in Malaysia, 17 Jul 2010 to 24 Jul 2010, International AIDS Society, (International)

Respondent Driven Sampling Involving the Community, XV111 International AIDS Conference July 2010. Vienna. Respondent Driven Sampling Involving the Community, 17 Jul 2010 to 24 Jul 2010, International AIDS Society, (International)

, MMA SECOND SEMINAR ON POSTGRADUATE MEDICAL EDUCATION, 26 Jan 2013 to 26 Jan 2013, Malaysian Medical Association, (National)

SUPERVISION

 
Post Graduate Level
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Completed

Masters Degree, Dr Leong Chee Loong, ADVANCED TRAINING IN INFECTIOUS DISEASES, 2008/2009

Masters Degree, Dr James Koh, ADVANCED TRAINING IN INFECTIOUS DISEASES, 2008/2009

Masters Degree, Dr Sufian Adnan, MMed, 2008/2009

Doctoral Degree (PhD), Tee Kok Keng, PhD, 2008/2009

Masters Degree, Dr Sufian Adnan, MMed, 2007/2008

Masters Degree, Dr Sufian Adnan, MMed, 2006/2007

Masters Degree, Dr Muhammad Zainafyah Bin Zakaria, MMed, 2004/2005

Masters Degree, Dr Wong Chew Ming, MMed, 2004/2005

Ongoing

Doctoral Degree (PhD), Tan Hong Yien, PhD, 2009/2010

Masters Degree, Martin Choo, MSC, 2009/2010

Doctoral Degree (PhD), Yong Yean Kong, PhD, 2009/2010

Masters Degree, Tunku Noor Hayati Binti Tunku Abdul Rahman, MSC, 2009/2010

Doctoral Degree (PhD), Dr Salwa Mudddthir Ismail Norien, PhD, 2009/2010

Masters Degree, Dr Azureen Azmel, MMed, 2008/2009

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).

Chairperson - Consensus Guidelines on the management of Staphylococcus aureus infections, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 1999, (National)

Co-Chairperson - Consensus meeting on the use of antiretroviral therapy in Malaysia, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001, (National)

Member, Expert Panel - Consensus on the use of antiretroviral therapy in emerging nations, BMS, 1998, (International)

Member, Expert Panel - National Consensus Guidelines for the Management of Extended-spectrum Beta-Lactamase Producing Bacteria, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001, (National)

Member, Technical Expert Panel - UNAIDS Regional Task Force on IDU, consultative meeting, UNAIDS, 2005, (International)

Co-chairperson, Scientific Program Committee International AIDS Conference, Vienna 2010, International AIDS Society , 2010, 24, (International)

Member, Oversight Committee for the Second Independent Evaluation of UNAIDS, UNAIDS, 2008, 24, (International)

Member, United Nations Reference Group on HIV and Injecting Drug Use, United Nations , 2007, 24, (International)

Member, United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, United Nations, 2006, 24, (International)

Advisory Board Member, UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, UNAIDS, 2006, 24, (International)

Executive Committee Member, International Harm Reduction Association, International Harm Reduction Association, 2006, 24, (International)

Advisory Board Member, International Harm Reduction Development, International Harm Reduction Development, 2006, 24, (International)

Vice-Chair, Global Initiatives Committee- Foundation for AIDS Research (amfAR), amfAR, 2006, 24, (International)

Steering Committee Member. TREAT Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. American Foundation for AIDS Research (amfAR), amfAR, 2005, 24, (International)

Steering Committee Member, Asian Network on Surveillance of Resistant Pathogens (ANSORP), ANSORP, 2005, 24, (International)

Executive Committee Member, International Society for Infectious Diseases (ISID), 2008, (International)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).

Country Coordinating Mechanism , The Malaysian Global Fund, Country Coordinating Mechanism , The Malaysian Global Fund, Vice Chair / Member, 2009-Present, (National)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).

Subspeciality Training Subcommittee, (Government), 28-Sep-12 until 27-Sep-14

National Specialist Register, (National), 20-Jun-12

Executive Committee, Malaysian AIDS Council, (National), 01-Jan-10 until 31-Dec-12

Vice-Chair, Country Coordinating Mechanism, The Malaysian Global Fund Initiative ., (National), 01-Jan-09 until 31-Jul-09

Member, National Health Promotions Board, (National), 01-Jan-08 until 01-Apr-10

President Malaysian AIDS Council, (National), 01-Jan-06 until 01-Apr-10

Malaysian AIDS Foundation - Chairman, (National), 01-Jan-06

Member, National Infection Control and Antibiotic Committee, Ministry of Health, (National), 01-Jan-05

Member, National Task Force on Harm Reduction, Ministry of Health Malaysia, (National), 01-Jan-05

Convenor, Malaysian Harm Reduction Working Group, (National), 01-Jan-04